Pharmacogenomics of Warfarin in Hispanics and Latinos
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- University of Arizona
- Study ID
- NCT02972385
- Status
- Recruiting
Conditions
- Hemorrhage
- Thrombosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Mouthwash sample — PROCEDUREA one time mouthwash sample will be performed.
- Blood Draw — PROCEDUREPatients who are receiving a blood draw during their regular clinical appointment will be asked for a blood sample of 15 milliliters. Genomic DNA will be isolated for genotyping and patient plasma samples will also be stored.
Study Details
Warfarin is a commonly used blood thinner to treat and prevent blood clots. It is important to take the right dose of warfarin because too much can increase the risk of bleeding and too little can increase the risk of blood clots. This is why patients are closely monitored especially when they begin warfarin therapy. When clinicians prescribe warfarin, they have to consider different factors such as patient's age, body size, diet, and other medications that can interact with warfarin. Certain genes have also been found to affect warfarin dose. Individuals have variations in these genes, which can help explain why some patients need higher dose and others require less. These factors have been used to better predict a patient's warfarin dose requirement. However, these predictions were created based on Caucasian populations and they may not be accurate in predicting a safe warfarin dose if a patient is not Caucasian. This study aims to identify new genetic variation that affects warfarin dosing in Hispanic and Latino populations and try to better predict a Hispanic or Latino patient's warfarin dose requirement.
Key Dates
- Start date
- Sep 30, 2016
- Status verified
- Jun 2024
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 400 participants (estimated)
Primary Outcome Measure
Stable warfarin dose [ Time Frame: At time of enrollment ]
Central Contacts
- Jason H Karnes, PharmD, PhD520-626-1447
- Talin A Robinson Catalan, MS520-278-6114
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner University Medical Center - Tucson | Tucson | Arizona | 85721 |
Find similar trials in Tucson, AZ
Related Studies
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) TrialPHASE2 · Recruiting · Jason Sperry · Tucson, Arizona
- Onyx™ Liquid Embolic IDE Clinical StudyRecruiting · Medtronic Endovascular · Phoenix, Arizona
- NIRS Monitoring in Premature InfantsRecruiting · Boston Children's Hospital · Boston, Massachusetts